Phase II study of S-1 and docetaxel combination in advanced or recurrent gastric cancer.

被引：0
|
作者：
Yoshida, K
Toge, T
Ninomiya, M
Takakura, N
Hirabayashi, N
Takiyama, W
Sato, Y
Terashima, M
Goto, M
Sakamoto, J
Nishiyama, M
机构：
[1] Hiroshima Univ, Hiroshima, Japan
[2] Hiroshima City Hosp, Hiroshima, Japan
[3] Hiroshima Asa City Hosp, Hiroshima, Japan
[4] Hokkaido Univ, Sapporo, Hokkaido, Japan
[5] Fukushima Med Univ, Fukushima, Japan
[6] Kyoto Univ, Kyoto, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320S / 320S
页数：1
相关论文
共 50 条
  • [31] Phase II study of S-1 in combination with paclitaxel as a first-line treatment for patients with advanced/recurrent gastric cancer
    Toh, U.
    Yamana, H.
    Koufuji, K.
    Mine, T.
    Aoyagi, K.
    Miyagi, M.
    Imaizumi, T.
    Shirouzu, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] A multicenter phase II study of combination therapy with oral S-1 plus cisplatin in elderly patients with advanced gastric cancer.
    Terazawa, Tetsuji
    Iwasa, Satoru
    Sasaki, Yusuke
    Okazaki, Shunsuke
    Goto, Masahiro
    Kojima, Yasushi
    Naganuma, Atsushi
    Nagashima, Kengo
    Hirano, Hidekazu
    Honma, Yoshitaka
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [33] Phase II study of docetaxel combined with cisplatin in advanced gastric cancer.
    Park, YS
    Park, KW
    Lee, J
    Kang, JH
    Kim, HY
    Park, JO
    Lee, SH
    Kang, WK
    Park, K
    Lee, SI
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 327S - 327S
  • [34] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Yasushi Sato
    Tetsuji Takayama
    Tamotsu Sagawa
    Yasuo Takahashi
    Hiroyuki Ohnuma
    Syunichi Okubo
    Naoaki Shintani
    Shingo Tanaka
    Masaya Kida
    Yasuhiro Sato
    Hidetoshi Ohta
    Koji Miyanishi
    Tsutomu Sato
    Rishu Takimoto
    Masayoshi Kobune
    Koji Yamaguchi
    Koichi Hirata
    Yoshiro Niitsu
    Junji Kato
    [J]. Cancer Chemotherapy and Pharmacology, 2010, 66 : 721 - 728
  • [35] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Sato, Y.
    Takayama, T.
    Sagawa, T.
    Tanaka, S.
    Takahashi, S.
    Takimoto, R.
    Kato, J.
    Ohnuma, H.
    Takahashi, Y.
    Niitsu, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Sato, Yasushi
    Takayama, Tetsuji
    Sagawa, Tamotsu
    Takahashi, Yasuo
    Ohnuma, Hiroyuki
    Okubo, Syunichi
    Shintani, Naoaki
    Tanaka, Shingo
    Kida, Masaya
    Sato, Yasuhiro
    Ohta, Hidetoshi
    Miyanishi, Koji
    Sato, Tsutomu
    Takimoto, Rishu
    Kobune, Masayoshi
    Yamaguchi, Koji
    Hirata, Koichi
    Niitsu, Yoshiro
    Kato, Junji
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 721 - 728
  • [37] Phase I Study of Docetaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer
    Hironaka, Shuichi
    Yamazaki, Kentaro
    Taku, Keisei
    Yokota, Tomoya
    Shitara, Kohei
    Kojima, Takashi
    Ueda, Shinya
    Machida, Nozomu
    Muro, Kei
    Boku, Narikazu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (11) : 1014 - 1020
  • [38] A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer
    Naoki Uemura
    Shohei Kikuchi
    Yasushi Sato
    Hiroyuki Ohnuma
    Koichi Okamoto
    Hiroshi Miyamoto
    Masahiro Hirakawa
    Tamotsu Sagawa
    Koshi Fujikawa
    Yasuo Takahashi
    Toshinori Okuda
    Shinya Minami
    Minoru Takahashi
    Tetsuro Okamoto
    Kohichi Takada
    Koji Miyanisi
    Tetsuji Takayama
    Junji Kato
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 80 : 707 - 713
  • [39] Phase I/II study of docetaxel (DOC) and S-1 for patients (pts) with advanced gastric cancer (AGC).
    Hyodo, I
    Yamaguchi, K
    Koizumi, W
    Narahara, H
    Kato, T
    Akiya, T
    Sakata, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 323S - 323S
  • [40] Combination chemotherapy of S-1, docetaxel and CDDP for the treatment of advanced gastric cancer
    Niitsu, Yoshiro
    Takayama, Tetsuji
    Sato, Yasushi
    Sagawa, Tamotsu
    Abe, Seichiro
    Kato, Junji
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 313 - 314
12345